Online Zoom Link: https://ucl.zoom.us/j/94324808976

One of the most common side effects of standard anti-depressant treatments (i.e. SSRIs) is emotional blunting. Conversely, evidence from psychedelic depression trials suggest that patients may experience an increase in emotional responsiveness. This talk will present some recent data from the Imperial psilocybin/depression trials which look at the neural correlates of these effects, using emotion and music stimuli.

Matt Wall:

Matthew Wall is a Senior Imaging Scientist at Invicro LLC, and an honorary Senior Lecturer at Imperial College London. His work focuses on the application of neuroimaging (particularly fMRI) in neuropsychopharmacology and translational drug development. He has specific interests in work with psychedelics, cannabis, sex hormones, and in developing and improving neuroimaging methodology.